共 39 条
[1]
Rothwell PM(2006)Recent advances in management of transient ischaemic attacks and minor ischaemic strokes Lancet Neurol 5 323-331
[2]
Buchan A(2000)Short-term prognosis after emergency department diagnosis of TIA JAMA 284 2901-2906
[3]
Johnston SC(2005)Intravenous heparin started within the first 3 hours after onset of symptoms as a treatment for acute nonlacunar hemispheric cerebral infarctions Stroke 36 2415-2420
[4]
Johnston SC(2000)Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: a double-blind randomised study. HAEST Study Group. Heparin in acute embolic stroke trial Lancet 355 1205-1210
[5]
Gress DR(2012)Bleeding during treatment with aspirin versus apixaban in patients with atrial fibrillation unsuitable for warfarin: the apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment (AVERROES) trial Stroke 43 3291-3297
[6]
Browner WS(2006)Improving the quality of consent to randomised controlled trials by using continuous consent and clinician training in the consent process J Med Ethics 32 439-443
[7]
Sidney S(2007)Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack Lancet 369 283-292
[8]
Camerlingo M(2007)Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial Lancet Neurol 6 961-969
[9]
Salvi P(2013)Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association Stroke 44 870-947
[10]
Belloni G(1996)A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee Lancet 348 1329-1339